Lifesaving Cancer Drugs May in Rare Cases Threaten the Heart
December 6, 2016
‘Tidal wave of Hep. C coming,’ health commissioner warns
December 6, 2016
Show all

Fresno man goes to extreme lengths to fight multiple sclerosis

A man with multiple sclerosis hopes to get stem cell treatment.

A Fresno man is taking his fight against multiple sclerosis beyond the country’s borders.

He’s seeking an effective treatment that’s available at most major US hospitals but not for MS patients. Every walk around his Fresno neighborhood is a victory for Brian Melton against the disease that, most of the time, holds him hostage in his own home.

“It’s like a roller-coaster ride,” he said. “Every day is different. Some days I feel okay. Some days I feel awful, where I just want to lay in bed all day.”

Brian has multiple sclerosis. Since his diagnosis in 2005, the auto-immune disease has robbed him of the career and the activities he loved and stolen time away from the people he loves.

“There’s days when I have a lot of pain,” he said.

In MS, for unknown reasons, the body’s immune system destroys the myelin sheath around nerve fibers. The sheath is essential for communication between the brain and the body, much like an electrical cord. When the sheath is damaged, it leads to lesions in the brain and spinal cord and patients eventually lose their ability to think and move. Brian takes multiple medications to manage the disease and they’re not cheap.

“$5,000 to $6,000 a month for 30 pills,” Melton said, and the drugs have major side effects. “Lots of weird things in my mind with how I pronounce words and numbness, like burning legs now.”

Read Full Article: Fresno man goes to extreme lengths to fight multiple sclerosis

Read Full Article: Fresno man goes to extreme lengths to fight multiple sclerosis

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.